Regenxbio | 8-K: REGENXBIO Reports First Quarter 2024 Financial Results and Recent Operational Highlights
Regenxbio | DEFA14A: Others
Regenxbio | DEF 14A: Definitive information statements
Regenxbio | 8-K: Current report
Regenxbio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Regenxbio | 8-K: REGENXBIO Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights
Regenxbio | 8-K: REGENXBIO Announces Updated Strategic Plans and Third Quarter 2023 Financial Results
Regenxbio | 8-K: Current report
Regenxbio | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Regenxbio | 8-K: REGENXBIO Reports Second Quarter 2023 Financial Results and Recent Operational Highlights
Regenxbio | 8-K: Current report
Regenxbio | 8-K: REGENXBIO Reports First Quarter 2023 Financial Results and Recent Operational Highlights
Regenxbio | DEFA14A: Others
Regenxbio | DEF 14A: Definitive proxy statements
Regenxbio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Regenxbio | 8-K: REGENXBIO Reports Fourth Quarter 2022 and Full-Year 2022 Financial Results and Recent Operational Highlights
Regenxbio | 8-K: Current report
Regenxbio | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Regenxbio | 8-K: REGENXBIO Reports Third Quarter 2022 Financial Results and Recent Operational Highlights
Regenxbio | 8-K: REGENXBIO Reports Second Quarter 2022 Financial Results and Recent Operational Highlights
No Data